SpA patients | |
---|---|
Total number | 56 |
Age (mean ± SD) | 46 ± 16 |
Male/female | 32 (57%)/24 |
Known duration of the SpA : | 46 (82%) |
Average (min-max) | 6 years (2 weeks–30 years) |
Known HLAB27 status : | 39 (70%) |
HLAB27 positive/negative | 23 (59%)/16 |
Known therapeutic treatment : | 53 (95%) |
Without therapeutic treatment | 13 (25%) |
Treated with NSAIDs | 22 (42%) |
Treated with corticosteroids | 26 (49%) |
Treated with DMARDs | 27 (51%) |
Including anti-TNF-α biotherapies | 10 (19%) |